TABLE 1.
Groups | Parameters assessed |
|||
ALT (IU/L) | AST (IU/L) | ALP (IU/L) | LDH (ng/mL) | |
Control | 33.42 ± 1.92 | 27.42 ± 3.15 | 267.28 ± 15.63 | 21.83 ± 1.20 |
MTX | 50.71 ± 3.67a | 34.71 ± 2.78a | 458 ± 34.91a | 38.48 ± 3.62a |
VC 100 | 30.28 ± 1.16b | 30.85 ± 1.51 | 200.91 ± 21.01b | 22.89 ± 1.53b |
VC 200 | 26.00 ± 3.54b | 26.14 ± 2.27b | 126.00 ± 11.85b | 18.40 ± 1.52b |
CUR 10 | 43.38 ± 3.16 | 31.23 ± 3.51 | 315.91 ± 31.21b | 12.7 ± 2.496b |
CUR 20 | 36.00 ± 2.54b | 28.34 ± 2.16b | 256.00 ± 13.5b | 11.66 ± 3.22b |
VC100 + CUR 10 | 27.63 ± 3.64bd | 27.48 ± 3.5b | 188.32 ± 18.5bcd | 10.82 ± 1.22bc |
Data are expressed as mean ± standard deviation (n = 7 per group). Significant difference vs. arespective control saline, brespective MTX group, crespective 100 mg/kg vitamin C group, drespective 10 mg/kg curcumin group, each at p<0.05.